OCD Trial, Recruiting NCT06941155 Sponsor: Dokuz Eylul University Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT06941155
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been officially diagnosed with obsessive-compulsive disorder (OCD) by a licensed mental health professional using a standard diagnostic interview
  • You are not currently having thoughts of suicide or experiencing symptoms like hallucinations or losing touch with reality
  • You have access to the internet and a mobile phone
  • You have been taking the same psychiatric medication(s) at the same dose for at least one month before joining, and do not expect any dose changes during the 4-week study period
  • You do not have any neurological or other medical condition that would make it difficult to take part
  • You are able to see and tell apart different colors (for example, you do not have color blindness)
  • You are not currently taking part in any other research study involving a treatment or intervention
  • You are not currently receiving any other form of psychological therapy or treatment

Who may not be able to join:

  • You are currently having thoughts of suicide or are experiencing symptoms such as hallucinations or psychosis
  • Your psychiatric medication dose has changed in the past month, or a change is expected during the study period
  • You have a significant neurological or medical illness that could interfere with taking part
  • You have a visual condition, such as color blindness, that would prevent you from accurately seeing colored images used in the study
  • You are currently enrolled in another clinical trial that involves a psychological treatment or intervention
  • You are currently receiving any other psychological therapy or treatment outside of this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sıla Derin, PhD, Dokuz Eylul University, İzmir, Turkey

Phone: +905543366293

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dokuz Eylul University
Registry
ClinicalTrials.gov
Start date
14 May 2025
Est. completion
2 April 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Yale-Brown Obsessive Compulsive Scale; Obsessive Beliefs Questionnaire-44; OC bias index; Dot-Probe Task with Eye-Tracking

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov